Filter Results:
(659)
Show Results For
- All HBS Web
(659)
- People (2)
- News (222)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (180)
Show Results For
- All HBS Web
(659)
- People (2)
- News (222)
- Research (298)
- Events (4)
- Multimedia (12)
- Faculty Publications (180)
- March 2011 (Revised February 2012)
- Case
Innovation and Growth at Actelion Ltd.
By: Gary P. Pisano, Daniela Beyersdorfer and Ruth Dittrich
In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven... View Details
Keywords: Business Model; Talent and Talent Management; Innovation and Management; Leadership; Growth and Development Strategy; Product Development; Organizational Culture; Research and Development; Biotechnology Industry; Pharmaceutical Industry; Switzerland
Pisano, Gary P., Daniela Beyersdorfer, and Ruth Dittrich. "Innovation and Growth at Actelion Ltd." Harvard Business School Case 611-065, March 2011. (Revised February 2012.)
- May 11, 2020
- Article
Steer Your Family Businesses Through an Unplanned Transition
By: Josh Baron and Nick Di Loreto
In a perfect world, family businesses will transition leadership from one generation to the next along a predictable and well-planned process — whether that’s determined within the business, the ownership group, or the family itself — passing the baton after years of... View Details
Baron, Josh, and Nick Di Loreto. "Steer Your Family Businesses Through an Unplanned Transition." Harvard Business Review (website) (May 11, 2020).
- 2019
- Article
Pay-for-Monopoly?: An Assessment of Reverse Payment Deals by Pharmaceutical Companies
By: Sana Rafiq and Max Bazerman
Abstract
Over the past eighteen years, pharmaceutical firms have developed a blueprint to impede competition in order
to maintain their monopoly profits. This scheme, termed pay-for-delay, involves direct or indirect payment of
money from a branded-drug manufacturer... View Details
Rafiq, Sana, and Max Bazerman. "Pay-for-Monopoly? An Assessment of Reverse Payment Deals by Pharmaceutical Companies." Journal of Behavioral Economics for Policy 3, no. 1 (2019): 37–43.
- March 2009 (Revised September 2010)
- Case
Dartmouth-Hitchcock Medical Center: Spine Care
By: Robert S. Huckman, Michael E. Porter, Rachel Gordon and Natalie Kindred
Describes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in... View Details
Keywords: Health Care and Treatment; Medical Specialties; Service Delivery; Service Operations; Integration; Value Creation; Health Industry; United States
Huckman, Robert S., Michael E. Porter, Rachel Gordon, and Natalie Kindred. "Dartmouth-Hitchcock Medical Center: Spine Care." Harvard Business School Case 609-016, March 2009. (Revised September 2010.)
- 01 Sep 2009
- First Look
First Look: September 1
industries and poor selection of investments within industries. Venture capital organizations with more experience tend to outperform those with less experience. Practicing Medicine in the Age of Facebook Author:Sachin H. Jain... View Details
Keywords: Martha Lagace
- 14 Aug 2007
- Working Paper Summaries
Improving Patient Outcomes: The Effects of Staff Participation and Collaboration in Healthcare Delivery
- 2024
- Chapter
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." Chap. 4 in The Economics of Artificial Intelligence: Health Care Challenges, edited by Ajay Agrawal, Joshua Gans, Avi Goldfarb, and Catherine E. Tucker, 107–138. Chicago and London: University of Chicago Press, 2024.
- October 2017 (Revised August 2020)
- Case
RB
By: Joshua Margolis, Vincent Dessain and Jerome Lenhardt
As 2016 was approaching its end, Rakesh Kapoor, CEO of RB, one of the world’s major fast moving consumer goods (FMCG) companies, envisioned the prospect of a major acquisition that would add a line of health-related products that promised growth in the developing... View Details
- June 2008
- Article
Current State of Fellowship Hiring: Is a Universal Match Necessary? Is It Possible?
By: Christopher D. Harner, Anil S. Ranawat, Muriel Niederle, Alvin E. Roth, Peter J. Stern, Shepard R. Hurwitz, William Levine, G. Paul DeRosa and Serena S. Hu
Currently, approximately ninety percent of the six hundred twenty graduating orthopaedic residents are planning on entering a post-graduate fellowship. Since January of 2005, two of the largest fellowship match programs, Sports Medicine and Spine Surgery, were... View Details
Keywords: Medical Specialties; Recruitment; Selection and Staffing; Employment; Market Timing; Marketplace Matching; Health Industry
Harner, Christopher D., Anil S. Ranawat, Muriel Niederle, Alvin E. Roth, Peter J. Stern, Shepard R. Hurwitz, William Levine, G. Paul DeRosa, and Serena S. Hu. "Current State of Fellowship Hiring: Is a Universal Match Necessary? Is It Possible?" Journal of Bone and Joint Surgery: American Volume 90 (June 2008): 1375–1384.
- Web
Health Policy (Management) - Doctoral
(2021-2024); University of Pennsylvania, Perelman School of Medicine, Assistant Professor (2024-) Advisors: Michael Chernew , Robert S. Huckman , and Jay W. Lorsch A Jay Holmgren, 2021 University of California-San Francisco, School of View Details
- May 2016
- Article
Transformation of Health Care—Perspectives of Opinion Leaders
By: Joanne Disch, Thomas W. Feeley, Diana J. Mason, Richard L. Schilsky, Ellen L. Stovall and Shelley Fuld Nasso
"What Health System Transformations Do You Believe Are Necessary for the Future of Health Care?" We need to transform to a true value-based health care delivery system. That means organizing care around medical conditions, not simply around hospitals and doctors. We... View Details
- 27 May 2009
- First Look
First Look: May 27, 2009
remain about Marquee's staying power, rising costs, and increased competition. When is the right time for Tepperberg to pull the plug on Marquee? Purchase this case: http://hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=509019 Merck: Global Health and Access to... View Details
Keywords: Martha Lagace
- Web
VBHCD Intensive Seminars - Institute For Strategy And Competitiveness
professionals across the industry. Past participants have a background in one or several of the following health care specialty areas: clinical medicine (practitioners and trainees), executive administration/ management,... View Details
- Web
Placement - Doctoral
Dissertation: Pairing Purpose with Profit Advisors: Julie Battilana (Chair), Dutch Leonard , and A.J. Casey A Jay Holmgren Health Policy (Management), 2021 Placement: University of California-San Francisco, School of Medicine... View Details
- 2022
- Working Paper
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
- Web
Site Map
Society Kraft Precision Medicine Accelerator Laboratory for Innovation Science at Harvard Leadership Managing the Future of Work Public Education Leadership Project Private Capital Project Race, Gender & Equity Research Associates... View Details
- 10 Oct 2007
- First Look
First Look: First Look: October 10
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507082 PublicationsRealizing the Promise of Personalized Medicine Authors:Mara G. Aspinall and Richard G. Hamermesh Periodical:Harvard Business Review 85, no. 10 (October... View Details
Keywords: Martha Lagace
- 25 Jan 2024
- Research & Ideas
Being a Team Player: Why College Athletes Succeed in Business
degrees. 12 percent had law degrees. 5 percent were physicians. “Going into business, you're generally working with others as opposed to, say, a field like medicine or a field like academics; those tend to be a little more solitary,”... View Details
Keywords: by Rachel Layne
- Web
Hiring Organizations
Garage, Inc. Dior DNX Ventures Doltcini O'Shea UCI Continental Cycling Team DoorDash Dow, Inc. Downing Capital Group Draper Richards Kaplan Foundation Duetti Inc. Duolingo Dura Software Dust - dust.tt E E-Liability Institute Eastern Communications Ltd. eBay Edgeless... View Details
- Article
A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018
By: J. Chirenda, B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison and R. S. Kaplan
Background: This study used process maps and time-driven activity-based costing to document TB service delivery processes. The analysis identified the resources required to sustain TB services in Zimbabwe, as well as several opportunities for more effective and... View Details
Keywords: Time-Driven Activity-Based Costing; Provider Cost; Health Care and Treatment; Cost Management; Activity Based Costing and Management; Zimbabwe
Chirenda, J., B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison, and R. S. Kaplan. "A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018." BMC Health Services Research 21, no. 242 (2021).